This is comparable to the numbers of acute HEV described in neurological diseases such as GBS (1.2%) [16] and encephalitis (1.7%) [18], however, none of the GBS patients in our study presented with elevated anti-HEV-IgM. The gene discussed is CD40LG; the disease is Guillain-Barre syndrome.